In a filing, BeOne Medicines Ltd ADR revealed its SVP, General Counsel Lee Chan Henry unloaded Company’s shares for reported $0.18 million on Jun 06 ’25. In the deal valued at $256.11 per share,700 shares were sold. As a result of this transaction, Lee Chan Henry now holds 0 shares worth roughly $0.0.
Then, Wang Lai sold 1,402 shares, generating $353,853 in total proceeds. Upon selling the shares at $252.39, the Global Head of R&D now owns 0 shares.
Before that, Wu Xiaobin sold 1,934 shares. BeOne Medicines Ltd ADR shares valued at $489,591 were divested by the President and COO at a price of $253.15 per share. As a result of the transaction, Wu Xiaobin now holds 0 shares, worth roughly $0.0.
RBC Capital Mkts initiated its BeOne Medicines Ltd ADR [ONC] rating to an Outperform in a research note published on April 07, 2025; the price target was $312. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “a Buy”. JMP Securities started covering the stock on September 18, 2024. It rated ONC as “a Mkt outperform”.
Price Performance Review of ONC
On Tuesday, BeOne Medicines Ltd ADR [NASDAQ:ONC] saw its stock fall -0.14% to $263.42. Over the last five days, the stock has gained 4.65%. BeOne Medicines Ltd ADR shares have risen nearly 42.61% since the year began. Nevertheless, the stocks have risen 67.14% over the past one year.
How much short interest is there in BeOne Medicines Ltd ADR?
A steep rise in short interest was recorded in BeOne Medicines Ltd ADR stocks on 2025-05-15, growing by 40076.0 shares to a total of 2.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 1.99 million shares. There was a rise of 1.97%, which implies that there is a positive sentiment for the stock.
